EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Genetic Knockout of Can f 1, the Major Allergen in Dogs

Matt W G Walker iD, Carol Margolis, Tanner Wiegand, Nicholas Gavin, Elizabeth Loewy

The CRISPR Journal · 01.12.2026 · 9 (5-6) · 254-262

DOI: 10.1177/25731599261473124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 05.08.2026. Verfasst von Matt W G Walker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kindred Companion Sciences, New York, New York, USA. Hauptthemen laut MEDLINE: Allergens, Gene Knockout Techniques, Hypersensitivity, Lipocalins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dog allergy is a prevalent IgE-mediated condition, with the salivary lipocalin Can f 1 accounting for the majority of dog-specific IgE reactivity in sensitized individuals. Existing strategies for managing dog allergy primarily rely on modulating host immune responses and do not address allergen production at its source. Here, we report the generation of genetically engineered dogs lacking Can f 1. Using CRISPR-Cas9 editing and somatic cell nuclear transfer, we produced two healthy beagle puppies carrying a frameshift mutation in exon 1 of the Can f 1 gene. Salivary and hair/dander analysis demonstrated the absence of Can f 1 protein in the edited dogs. Skin prick testing in a sensitized individual demonstrated robust IgE-mediated reactivity to control dog extracts but no detectable response to extracts from the edited dogs. Together, these findings demonstrate that targeted genetic knockout of the major dog allergen is compatible with canine development and can abolish the IgE-mediated allergic response, supporting the feasibility of a gene-based approach to reducing canine allergenicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllergensGene Knockout TechniquesHypersensitivityLipocalinsAnimalsDogsImmunoglobulin ECRISPR-Cas SystemsFrameshift MutationAnimals, Genetically ModifiedSkin Tests

Substanzen

AllergensImmunoglobulin Eallergen Can f ILipocalins

Autor:innen und Institutionen

  • Kindred Companion Sciences, New York, New York, USA.
  • Comprehensive Allergy Clinic, New York, New York, USA.

ORCID-Profile: Matt W G Walker

Zitieren

APA

Walker, M. W. G., Margolis, C., Wiegand, T., Gavin, N., & Loewy, E. (2026). Targeted Genetic Knockout of Can f 1, the Major Allergen in Dogs. The CRISPR Journal, 9(5-6), 254-262. https://doi.org/10.1177/25731599261473124

Vancouver

Walker MWG, Margolis C, Wiegand T, Gavin N, Loewy E. Targeted Genetic Knockout of Can f 1, the Major Allergen in Dogs. The CRISPR Journal. 2026;9(5-6):254-262. doi:10.1177/25731599261473124

BibTeX
@article{Walker2026,
  author = {Walker, Matt W G and Margolis, Carol and Wiegand, Tanner and Gavin, Nicholas and Loewy, Elizabeth},
  title = {Targeted Genetic Knockout of Can f 1, the Major Allergen in Dogs},
  journal = {The CRISPR Journal},
  year = {2026},
  volume = {9},
  number = {5-6},
  pages = {254--262},
  doi = {10.1177/25731599261473124}
}
Kostenlos starten →